Table 4.
Altered expression of insulin and IGF polypeptide and receptor genes in PD and DLB
| mRNA | CONTROL | PD | DLB | |||
|---|---|---|---|---|---|---|
| FRONTAL CORTEX | ||||||
| INR | 0.006 | ±0.0003 | 0.003 | ±0.001 | 0.004 | ±0.001 |
| IGF1R | 28.97 | ±2.44 | 12.94 | ±4.925 | 3.31 | ±1.277**† |
| IGF2R | 0.677 | ±0.048 | 0.553 | ±0.162 | 0.168 | ±0.059**† |
| Insulin | 0.001 | ±0.0002 | 0.001 | ±0.0003 | 0.0004 | ±0.0002 |
| IGF1 | 0.0002 | ±1E-05 | 0.001 | ±0.0001 | 0.0001 | ±3E-05 |
| IGF2 | 3.3E-5 | ±2.1E-5 | 5.0E-5 | ±2.2E-5 | 0.00 | ±0.00 |
| FRONTAL WHITE MATTER | ||||||
| INR | 0.006 | ±0.0004 | 0.001 | ±0.0003*** | 0.001 | ±0.0004*** |
| IGF1R | 43.5 | ±8.315 | 2.648 | ±0.291*** | 2.72 | ±0.842*** |
| IGF2R | 0.395 | ±0.009 | 0.324 | ±0.129 | 0.401 | ±0.127 |
| Insulin | 0.001 | ±7E-05 | 3E-05 | ±1E-05*** | 2E-05 | ±9E-06*** |
| IGF1 | 0.001 | ±0.0002 | 0.001 | ±0.0004 | 0.001 | ±0.0002 |
| IGF2 | 0.0002 | ±0.00001 | 3.7E-6 | ±9.6E-7*** | 7.2E-6 | ±5.2E-6*** |
| AMYGDALA | ||||||
| INR | 0.0134 | ±0.002 | 0.005 | ±0.001** | 0.004 | ±0.002** |
| IGF1R | 2.437 | ±0.477 | 30.43 | ±11.87** | 25.94 | ±7.56** |
| IGF2R | 0.527 | ±0.105 | 0.979 | ±0.241*** | 1.839 | ±0.622*** |
| Insulin | 0.017 | ±0.002 | 0.005 | ±0.003** | 0.003 | ±0.001** |
| IGF1 | 0.002 | ±0.0002 | 0.002 | ±0.001 | 0.002 | ±0.001 |
| IGF2 | 0.0002 | ±0.0001 | 0.0002 | ±0.0001 | 0.0004 | ±0.0002 |
| BASAL GANGLIA | ||||||
| INR | 0.0007 | ±0.0001 | 0.0004 | ±0.0002 | 0.001 | ±0.0002 |
| IGF1R | 0.7054 | ±0.0668 | 0.6963 | ±0.095 | 0.959 | ±0.210 |
| IGF2R | 0.0301 | ±0.0035 | 0.0867 | ±0.0301 | 0.229 | ±0.102* |
| Insulin | 8E-06 | ±3E-06 | 3E-06 | ±3E-06 | 4E-06 | ±2E-06 |
| IGF1 | 0.0004 | ±3E-05 | 0.0003 | ±8E-05 | 0.0005 | ±0.0001 |
| IGF2 | 0.000 | ±0.000 | 0.000 | ±0.000 | 0.000 | ±0.000 |
IN-insulin; IGF-insulin-like growth factor; R-receptor. Gene expression was measured by qRT-PCR analysis with values (×10−6) normalized to 18S rRNA measured in parallel reactions. Inter-group comparisons were made using repeated measures ANOVA with the post hoc Dunn's multiple comparison test.
P<0.05,
P<0.01,
P<0.005 relative to control;
P<0.05 or better relative to PD.